Tailin Bio: Shareholders High Investment intend to reduce their shareholding by no more than 1.5% of the company's shares.

Tailin Biotech announced that the concerted action person of the controlling shareholder and actual controller holding more than 5% of the shares, Gao De Investment Plan, plans to reduce its shareholding in the company by no more than 1,819,517 shares within 3 months after the announcement of the reduction plan, starting from the 15th trading day through centralized bidding, block trading, or a combination of both, accounting for 1.50% of the total share capital of the company. The reduction price will be determined based on the stock market price at the time of reduction.